These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19331213)

  • 21. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of small cell lung cancer treatment.
    Casas F; Viñolas N
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):461-81. PubMed ID: 15094182
    [No Abstract]   [Full Text] [Related]  

  • 23. Lenalidomide-induced interstitial lung disease.
    Chen Y; Kiatsimkul P; Nugent K; Raj R
    Pharmacotherapy; 2010 Mar; 30(3):325. PubMed ID: 20180616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current status and measures for lung injuries in cancer treatment].
    Kudoh S; Yoshimura A
    Gan To Kagaku Ryoho; 2004 May; 31(5):679-84. PubMed ID: 15170972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lung toxicity of cancer treatment].
    de Castro Carpeño J; Vilches Aguirre Y; González Barón M
    Med Clin (Barc); 1995 Nov; 105(17):661-8. PubMed ID: 8558967
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced interstitial lung diseases.
    Gockerman JP
    Clin Chest Med; 1982 Sep; 3(3):521-36. PubMed ID: 6751669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulmonary toxicity of antimitotic agent-radiotherapy combination].
    Cosset JM; Chirat E; Carde P; Moisson P; Girinski T; Tchernia G
    Therapie; 1986; 41(4):293-6. PubMed ID: 2437667
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary toxicity associated with spirogermanium.
    Dixon C; Hagemeister F; Legha S; Bodey G
    Cancer Treat Rep; 1984 Jun; 68(6):907-8. PubMed ID: 6733705
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxidant-induced lung injury in anticancer therapy.
    Beinert T; Binder D; Stuschke M; Jörres RA; Oehm C; Fleischhacker M; Sezer O; Mergenthaler HG; Werner T; Possinger K
    Eur J Med Res; 1999 Feb; 4(2):43-53. PubMed ID: 10066639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary complications of cancer treatment.
    Alberts WM
    Curr Opin Oncol; 1997 Mar; 9(2):161-9. PubMed ID: 9161795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic drug-induced lung injury.
    Snyder LS; Hertz MI
    Semin Respir Infect; 1988 Sep; 3(3):217-28. PubMed ID: 3055113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiotoxicity and pulmonary toxicity of chemotherapy].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):934-41. PubMed ID: 2188614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary toxicity of antineoplastic drugs.
    Batist G; Andrews JL
    JAMA; 1981 Sep; 246(13):1449-53. PubMed ID: 7265453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary toxicity of antineoplastic therapy.
    Kreisman H; Wolkove N
    Semin Oncol; 1992 Oct; 19(5):508-20. PubMed ID: 1411649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs that may induce pulmonary disease.
    Rosenow EC
    Geriatrics; 1978 Jan; 33(1):64-73. PubMed ID: 620927
    [No Abstract]   [Full Text] [Related]  

  • 37. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
    Noël-Savina E; Descourt R
    Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal pneumonitis in children with metastatic rhabdomyosarcoma following whole lung radiotherapy and sequential epirubicin.
    Prestwich RJ; Picton SV; Glaser A; Taylor RE
    Pediatr Blood Cancer; 2007 May; 48(5):586-90. PubMed ID: 16302221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
    Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
    Carver JR; Shapiro CL; Ng A; Jacobs L; Schwartz C; Virgo KS; Hagerty KL; Somerfield MR; Vaughn DJ;
    J Clin Oncol; 2007 Sep; 25(25):3991-4008. PubMed ID: 17577017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.